Your browser doesn't support javascript.
loading
The cancer survival index-A prognostic score integrating psychosocial and biological factors in patients diagnosed with cancer or haematologic malignancies.
Gaiger, Alexander; Lubowitzki, Simone; Krammer, Katharina; Zeilinger, Elisabeth L; Acel, Andras; Cenic, Olivera; Schrott, Andrea; Unseld, Matthias; Rassoulian, Anahita Paula; Skrabs, Cathrin; Valent, Peter; Gisslinger, Heinz; Marosi, Christine; Preusser, Matthias; Prager, Gerald; Kornek, Gabriela; Pirker, Robert; Steger, Günther G; Bartsch, Rupert; Raderer, Markus; Simonitsch-Klupp, Ingrid; Thalhammer, Renate; Zielinski, Christoph; Jäger, Ulrich.
Afiliação
  • Gaiger A; Department of Medicine I, Division of Haematology and Haemostaseology, Medical University of Vienna, Vienna, Austria.
  • Lubowitzki S; Department of Medicine I, Division of Haematology and Haemostaseology, Medical University of Vienna, Vienna, Austria.
  • Krammer K; Department of Medicine I, Division of Haematology and Haemostaseology, Medical University of Vienna, Vienna, Austria.
  • Zeilinger EL; Department of Medicine I, Division of Haematology and Haemostaseology, Medical University of Vienna, Vienna, Austria.
  • Acel A; Department of Medicine I, Division of Oncology, Medical University of Vienna, Comprehensive Cancer Centre, Medical University Vienna - General Hospital, Vienna, Austria.
  • Cenic O; Department of Medicine I, Division of Haematology and Haemostaseology, Medical University of Vienna, Vienna, Austria.
  • Schrott A; Statistikambulanz KG, Leobendorf, Austria.
  • Unseld M; Department of Medicine I, Division of Palliative Medicine, Medical University of Vienna, Vienna, Austria.
  • Rassoulian AP; Department of Medicine I, Division of Haematology and Haemostaseology, Medical University of Vienna, Vienna, Austria.
  • Skrabs C; Department of Medicine I, Division of Haematology and Haemostaseology, Medical University of Vienna, Vienna, Austria.
  • Valent P; Department of Medicine I, Division of Haematology and Haemostaseology, Medical University of Vienna, Vienna, Austria.
  • Gisslinger H; Ludwig Boltzmann Institute for Haematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Marosi C; Department of Medicine I, Division of Haematology and Haemostaseology, Medical University of Vienna, Vienna, Austria.
  • Preusser M; Department of Medicine I, Division of Oncology, Medical University of Vienna, Comprehensive Cancer Centre, Medical University Vienna - General Hospital, Vienna, Austria.
  • Prager G; Department of Medicine I, Division of Oncology, Medical University of Vienna, Comprehensive Cancer Centre, Medical University Vienna - General Hospital, Vienna, Austria.
  • Kornek G; Department of Medicine I, Division of Oncology, Medical University of Vienna, Comprehensive Cancer Centre, Medical University Vienna - General Hospital, Vienna, Austria.
  • Pirker R; Department of Medicine I, Division of Oncology, Medical University of Vienna, Comprehensive Cancer Centre, Medical University Vienna - General Hospital, Vienna, Austria.
  • Steger GG; Department of Medicine I, Division of Oncology, Medical University of Vienna, Comprehensive Cancer Centre, Medical University Vienna - General Hospital, Vienna, Austria.
  • Bartsch R; Department of Medicine I, Division of Oncology, Medical University of Vienna, Comprehensive Cancer Centre, Medical University Vienna - General Hospital, Vienna, Austria.
  • Raderer M; Department of Medicine I, Division of Oncology, Medical University of Vienna, Comprehensive Cancer Centre, Medical University Vienna - General Hospital, Vienna, Austria.
  • Simonitsch-Klupp I; Department of Medicine I, Division of Oncology, Medical University of Vienna, Comprehensive Cancer Centre, Medical University Vienna - General Hospital, Vienna, Austria.
  • Thalhammer R; Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria.
  • Zielinski C; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
  • Jäger U; Department of Medicine I, Division of Oncology, Medical University of Vienna, Comprehensive Cancer Centre, Medical University Vienna - General Hospital, Vienna, Austria.
Cancer Med ; 11(18): 3387-3396, 2022 09.
Article em En | MEDLINE | ID: mdl-35315594
ABSTRACT

OBJECTIVE:

We aimed to investigate whether (1) psychological and social indicators influence survival in patients diagnosed with cancer or haematologic malignancies when important biological aspects are controlled for, (2) psychological, social and biological indicators can be utilised to design one collated index for survival, usable in clinical practice to identify patients at risk of shorter survival and to improve personalised healthcare provision.

METHODS:

In this cross-sectional study, 2263 patients with cancer or haematologic malignancies participated. We analysed 15 biological, psychological and social indicators as risk factors for survival with a Cox proportional hazards model. Indicators significantly associated with survival were combined to compute models for the identification of patient groups with different risks of death. The training sample contained 1122 patients. Validation samples included the remaining 1141 patients, the total sample, as well as groups with different cancer entities.

RESULTS:

Five indicators were found to significantly impact survival Cancer site (HR 3.56), metastatic disease (HR 1.88), symptoms of depression (HR 1.34), female sex (HR 0.73) and anaemia (HR 0.48). Combining these indicators to a model, we developed the Cancer Survival Index, identifying three distinct groups of patients with estimated survival times of 47.2 months, 141 months and 198.2 months (p < 0.001). Post hoc analysis of the influence of depression on survival showed a mediating effect of the following four factors, related to both depression and survival previous psychiatric conditions, employment status, metastatic disease and haemoglobin levels.

CONCLUSIONS:

Psychosocial and biological factors impact survival in various malignancies and can be utilised jointly to compute an index for estimating the survival of each patient individually-the Cancer Survival Index.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores Biológicos / Neoplasias Hematológicas Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores Biológicos / Neoplasias Hematológicas Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article